Sundarlal Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 17-07-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.00 Cr
as on 17-07-2024
- Revenue -34.68%
(FY 2023)
- Profit -113.70%
(FY 2023)
- Ebitda -132.38%
(FY 2023)
- Net Worth -12.46%
(FY 2023)
- Total Assets -29.67%
(FY 2023)
About Sundarlal Pharma Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹7.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Amit Bishnoi, Gaurav Kumar, Prem Sethi, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909MH2018PTC315127
- Company No.
315127
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Oct 2018
- Date of AGM
05 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sundarlal Pharma Distributors?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Bishnoi  | Additional Director | 19-Mar-2024 | Current |
| Gaurav Kumar | Director | 30-Sep-2022 | Current |
| Prem Sethi | Director | 29-Dec-2018 | Current |
| Vikramaditya Ambre | Director | 01-Oct-2018 | Current |
Financial Performance and Corporate Structure Insights of Sundarlal Pharma Distributors.
Sundarlal Pharma Distributors Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.68% decrease. The company also saw a substantial fall in profitability, with a 113.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sundarlal Pharma Distributors?
In 2023, Sundarlal Pharma Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Galaxystar Pharma Distributors Private LimitedActive 6 years 2 monthsAmit Bishnoi, Gaurav Kumar and 1 more are mutual person
- Svs Lifesciences Private LimitedActive 2 years 7 months
Amit Bishnoi and Gaurav Kumar are mutual person
- Saurashtra Medisolutions Private LimitedActive 2 years 10 months
Amit Bishnoi and Gaurav Kumar are mutual person
- Barros Enterprises Private LimitedActive 5 years 3 months
Amit Bishnoi and Gaurav Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Sep 2020 | ₹7.00 Cr | Satisfied |
How Many Employees Work at Sundarlal Pharma Distributors?
Sundarlal Pharma Distributors has a workforce of 1 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sundarlal Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sundarlal Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
